Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?

Therapeutic Apheresis

Volumn 1, Issue 4, 1997, Pages 348-352

  Yamawaki, Takemori ^a,b   Suzuki, Norihiro ^a  

^a Mito Red Cross Hospital   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Guillain Barr syndrome Miller Fisher syndrome; Immunoadsorbent column; Immunoadsorption plasmapheresis; Lupoid sclerosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; COLLAGEN DISEASE; DEMYELINATING DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; METHODOLOGY; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; PLASMAPHERESIS; POLYRADICULONEUROPATHY; TREATMENT OUTCOME;

ADULT; COLLAGEN DISEASES; DEMYELINATING DISEASES; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; MILLER FISHER SYNDROME; MYASTHENIA GRAVIS; NERVOUS SYSTEM DISEASES; PLASMAPHERESIS; POLYRADICULONEUROPATHY; TREATMENT OUTCOME;

EID: 0031261255     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-9987.1997.tb00053.x     Document Type: Article

References (18)

1. Shibuya N, Sato T, Osama M, Takegami T, Doi S, Kawanami S. Immunoadsorption therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry 1994;57:578-81.
2. Grob D, Simpson D, Mitsumoto H, Hoch B, Mokhatarian F, Bender A, Greenberg M, Koo A, Nakayama S. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 1995;45:338-44.
3. Rosenow F, Haupt WF, Grieb P, Jimenez-Klingberg C, Borberg H. Plasma exchange and selective adsorption in Guillain-Barré syndrome. A comparison of therapies by clinical course and side effects. Transfus Sci 1993;14:13-5.
4. Matsugami K, Endo M, Kimata N, Watanabe Y, Oonuki T, Ando M, Nakazato S, Kubo K, Nihei H, Agishi T. Clinical evaluation of immunoadsorbance in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. Jpn J Apheresis 1994;13:160-1.
5. Ichikawa W, Nakayama T, Yasuoka H. Successful plasmapheresis in Fisher's syndrome. Jpn J Apheresis 1994;13: 157-8.
6. Koh C-S, Shimada K, Inoue A, Shimizu Y, Yanagisawa N, Shinoda T, Arakura H, Oguchi H. Immunoadsorption plasmapheresis in polymyositis/dermatomyositis: Beneficial effects in four cases. Jpn J Apheresis 1994;13:131-2.
7. Kleyweg RP, van der Meche FGA. Treatment-related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma exchange. J Neurol Neurosurg Psychiatry 1991;54:957-60.
8. Van der Meche FGA, Schmitz PIM, the Dutch Guillain-Barré study group. A randomized trial comparing immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-9.
9. Haupt WF, Rosenow F, van der Ven C, Borberg H, Pawlik G. Sequential treatment of Guillain-Barré syndrome with extra-corporeal elimination and intravenous immunoglobulin. Therapeu Apheresis 1997;1:55-7.
10. Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE, Griffin JW, MaKhann GM. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 1988;23:440-7.
11. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller-Fisher syndrome. Ann Neurol 1972;31:677-9.
12. Yuki N, Sato S, Tshji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 1993;43:414-7.
13. Yamawaki T, Sano M, Okamoto S, Suzuki N. Does phenylalanine-PVA immunoadsorbent column remove antiGQ1b antibodies in Miller-Fisher syndrome? J Neurol 1995;242 (Suppl 2):S142-3.
14. Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment. Neurology 1996;46:1644-51.
15. Yuki N, Miyatake T, Ohsawa T. Beneficial effect of plasmapheresis on Fisher's syndrome. Muscle Nerve 1993;16:1267-8.
16. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller-Fisher variant of Gullain-Barre syndrome and neurotransmitter release. Lancet 1994;343:454-5.
17. Fulford KWM, Carterall RD, Dethantry JJ, Doniach D, Kremer H. A collagen disorder of the nervous system presenting as multiple sclerosis. Brain 1973;95:373-86.
18. Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GRV. Lupoid sclerosis: A possible pathogenic role for antiphospholipid antibodies. Ann Rheum Dis 1985;44:281-3.